1. McGuire, S. World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. Advances in nutrition. 2016; 7: 418–419.
Google Scholar | Crossref | Medline2. Molnar, C, Molnar, S, Bedekovics, J, et al. Thyroid Carcinoma Coexisting with Hashimoto's Thyreoiditis: Clinicopathological and Molecular Characteristics Clue up Pathogenesis. Pathology oncology research : POR. 2019; 25: 1191–1197.
Google Scholar | Crossref | Medline3. Liu, Y, Lv, H, Zhang, S, Shi, B, Sun, Y. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma. Frontiers in endocrinology. 2021; 12: 772071.
Google Scholar | Crossref | Medline4. Yu, Z, Yu, Y, Wan, Y, et al. Iodine intake level and incidence of thyroid disease in adults in Shaanxi province: a cross-sectional study. Annals of translational medicine. 2021; 9: 1567.
Google Scholar | Crossref | Medline5. Albano, D, Dondi, F, Zilioli, V, et al. The role of Hashimoto thyroiditis in predicting radioiodine ablation efficacy and prognosis of low to intermediate risk differentiated thyroid cancer. Annals of nuclear medicine. 2021; 35: 1089–1099.
Google Scholar | Crossref | Medline6. Yao, Z, Fanslow, WC, Seldin, MF, et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity. 1995; 3: 811–821.
Google Scholar | Crossref | Medline | ISI7. Okada, S, Puel, A, Casanova, JL, Kobayashi, M. Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity. Clinical & translational immunology. 2016; 5: e114.
Google Scholar | Crossref | Medline8. Ruiz de Morales, JMG, Puig, L, Dauden, E, et al. Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies. Autoimmunity reviews. 2020; 19: 102429.
Google Scholar | Crossref | Medline9. Liu, X, Jin, H, Zhang, G, et al. Intratumor IL-17-positive mast cells are the major source of the IL-17 that is predictive of survival in gastric cancer patients. PloS one. 2014; 9: e106834.
Google Scholar | Crossref | Medline10. Liu, J, Duan, Y, Cheng, X, et al. IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochemical and biophysical research communications. 2011; 407: 348–354.
Google Scholar | Crossref | Medline | ISI11. Pan, B, Shen, J, Cao, J, et al. Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer. Scientific reports. 2015; 5: 16053.
Google Scholar | Crossref | Medline12. Hui, Z, Liu, Z, He, A, et al. Visfatin promotes the malignancy of human acute myeloid leukemia cells via regulation of IL-17. European journal of pharmacology. 2019; 853: 103–110.
Google Scholar | Crossref | Medline13. Ding, L, Hu, EL, Xu, YJ, et al. Serum IL-17F combined with VEGF as potential diagnostic biomarkers for oral squamous cell carcinoma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015; 36: 2523–2529.
Google Scholar | Crossref | Medline14. Bastid, J, Dejou, C, Docquier, A, Bonnefoy, N. The Emerging Role of the IL-17B/IL-17RB Pathway in Cancer. Frontiers in immunology. 2020; 11: 718.
Google Scholar | Crossref | Medline15. Esfahanian, F, Ghelich, R, Rashidian, H, Jadali, Z. Increased Levels of Serum Interleukin-17 in Patients with Hashimoto's Thyroiditis. Indian journal of endocrinology and metabolism. 2017; 21: 551–554.
Google Scholar | Crossref | Medline16. Han, LT, Hu, JQ, Ma, B, et al. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis. Diagnostic pathology. 2019; 14: 52.
Google Scholar | Crossref | Medline17. Grunewald, M, Kumar, S, Sharife, H, et al. Counteracting age-related VEGF signaling insufficiency promotes healthy aging and extends life span. Science. 2021; 373.
Google Scholar | Crossref | Medline18. Raghav, K, Liu, S, Overman, MJ, et al. Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma. Cancer discovery. 2021; 11: 2738–2747.
Google Scholar | Crossref | Medline19. Ren, Z, Chen, X, Hong, L, et al . Nanoparticle Conjugation of Ginsenoside Rg3 Inhibits Hepatocellular Carcinoma Development and Metastasis. Small. 2020; 16: e1905233.
Google Scholar | Crossref | Medline20. Chen, J, Yu, Y, Li, H, et al. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer. Molecular cancer. 2019; 18: 33.
Google Scholar21. Giuliani, N, Storti, P, Bolzoni, M, Palma, BD, Bonomini, S. Angiogenesis and multiple myeloma. Cancer microenvironment : official journal of the International Cancer Microenvironment Society. 2011; 4: 325–337.
Google Scholar | Crossref | Medline22. Molnar, S, Gyory, F, Nagy, E, Mehes, G, Molnar, C. [Clinico-pathological features of papillary thyroid cancer coexistent with Hashimoto's thyroiditis]. Orvosi hetilap. 2017; 158: 178–182.
Google Scholar | Medline23. M E and M S. Hashimoto's thyroiditis and papillary thyroid cancer: are they immunologically linked? Trends in endocrinology and metabolism: TEM. 2014; 25: 656–664.
Google Scholar | Crossref | Medline24. Wen, X, Wang, B, Jin, Q, Zhang, W, Qiu, M. Thyroid Antibody Status is Associated with Central Lymph Node Metastases in Papillary Thyroid Carcinoma Patients with Hashimoto's Thyroiditis. Annals of surgical oncology. 2019; 26: 1751–1758.
Google Scholar | Crossref | Medline25. Cortes, MCS, Rosario, PW, Mourao, GF, Calsolari, MR. Influence of chronic lymphocytic thyroiditis on the risk of persistent and recurrent disease in patients with papillary thyroid carcinoma and elevated antithyroglobulin antibodies after initial therapy. Brazilian journal of otorhinolaryngology. 2018; 84: 448–452.
Google Scholar | Crossref | Medline26. Hirokawa, M, Nishihara, E, Takada, N, et al . Warthin-like papillary thyroid carcinoma with immunoglobulin G4-positive plasma cells possibly related to Hashimoto's thyroiditis. Endocrine journal. 2018; 65: 175–180.
Google Scholar | Crossref | Medline27. Zirilli, G, Salzano, G, Corica, D, et al. Thyrotropin serum levels and coexistence with Hashimoto's thyroiditis as predictors of malignancy in children with thyroid nodules. Italian journal of pediatrics. 2019; 45: 96.
Google Scholar | Medline28. Lun, Y, Wu, X, Xia, Q, et al. Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngology--head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2013; 148: 396–402.
Google Scholar | SAGE Journals | ISI29. Ye, ZQ, Gu, DN, Hu, HY, Zhou, YL, Hu, XQ, Zhang, XH. Hashimoto's thyroiditis, microcalcification and raised thyrotropin levels within normal range are associated with thyroid cancer. World journal of surgical oncology. 2013; 11: 56.
Google Scholar | Crossref | Medline30. Gabalec, F, Srbova, L, Nova, M, et al. Impact of Hashimoto's thyroiditis, TSH levels, and anti-thyroid antibody positivity on differentiated thyroid carcinoma incidence. Endokrynologia Polska. 2016; 67: 48–53.
Google Scholar | Crossref | Medline31. Dong, S, Xia, Q, Wu, YJ. High TPOAb Levels (>1300 IU/mL) Indicate Multifocal PTC in Hashimoto's Thyroiditis Patients and Support Total Thyroidectomy. Otolaryngology--head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2015; 153: 20–26.
Google Scholar | SAGE Journals | ISI32. Ivanov, VK, Kashcheev, VV, Chekin, SY, et al . Radiation-epidemiological studies of thyroid cancer incidence in Russia after the Chernobyl accident (estimation of radiation risks, 1991–2008 follow-up period). Radiation protection dosimetry. 2012; 151: 489–499.
Google Scholar | Crossref | Medline33. Kesminiene, A, Evrard, AS, Ivanov, VK, et al. Risk of thyroid cancer among chernobyl liquidators. Radiation research. 2012; 178: 425–436.
Google Scholar | Crossref | Medline34. Albi, E, Cataldi, S, Lazzarini, A, et al. Radiation and Thyroid Cancer. International journal of molecular sciences. 2017; 18.
Google Scholar | Crossref35. Abend, M, Pfeiffer, RM, Port, M, et al. Utility of gene expression studies in relation to radiation exposure and clinical outcomes: thyroid cancer in the Ukrainian-American cohort and late health effects in a MAYAK worker cohort. International journal of radiation biology. 2020: 1–7.
Google Scholar | Medline36. Pellegriti, G, Frasca, F, Regalbuto, C, Squatrito, S, Vigneri, R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. Journal of cancer epidemiology. 2013; 2013: 965212.
Google Scholar | Crossref | Medline37. Vigneri, R, Malandrino, P, Vigneri, P. The changing epidemiology of thyroid cancer: why is incidence increasing? Current opinion in oncology. 2015; 27: 1–7.
Google Scholar | Crossref | Medline | ISI38. K G, A D, G K, et al. The association between thyroid carcinoma and Hashimoto's thyroiditis: the ultrasonographic and histopathologic characteristics of malignant nodules. Thyroid : official journal of the American Thyroid Association. 2010; 20: 873–878.
Google Scholar | Crossref | Medline39. SH, J, HS, H, EH, L, JJ, K. Papillary Thyroid Carcinoma Arising in Children and Adolescent Hashimoto's Thyroiditis: Ultrasonographic and Pathologic Findings. International journal of endocrinology. 2016; 2016: 2397690.
Google Scholar | Medline40. Schmidt, T, Luebbe, J, Paust, HJ, Panzer, U. Mechanisms and functions of IL-17 signaling in renal autoimmune diseases. Molecular immunology. 2018; 104: 90–99.
Google Scholar | Crossref | Medline41. Bossowski, A, Moniuszko, M, Idzkowska, E, et al. Decreased proportions of CD4 + IL17+/CD4 + CD25 + CD127− and CD4 + IL17+/CD4 + CD25 + CD127− FoxP3+ T cells in children with autoimmune thyroid diseases (.). Autoimmunity. 2016; 49: 320–328.
Google Scholar | Crossref | Medline42. Bossowski, A, Moniuszko, M, Idzkowska, E, et al. [Evaluation of CD4+CD161+CD196+ and CD4+IL−17+ Th17 cells in the peripheral blood of young patients with Hashimoto's thyroiditis and Graves' disease]. Pediatric endocrinology, diabetes, and metabolism. 2012; 18: 89–95.
Google Scholar | Medline43. Li, C, Yuan, J, Zhu, YF, et al. Imbalance of Th17/Treg in Different Subtypes of Autoimmune Thyroid Diseases. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology. 2016; 40: 245–252.
Google Scholar | Crossref | Medline44. Liu, Y, Tang, X, Tian, J, et al . Th17/Treg cells imbalance and GITRL profile in patients with Hashimoto's thyroiditis. International journal of molecular sciences. 2014; 15: 21674–21686.
Google Scholar | Crossref | Medline | ISI45. C, KD, B, AY, F, BT, et al . Circulating Th17 cytokine levels are altered in Hashimoto's thyroiditis. Cytokine. 2016; 80: 13–17.
Google Scholar | Crossref | Medline